John Barbieri, MD, MBA: Managing Isotretinoin Side Effects

Dr. Barbieri recaps his presentation from the acne symposium at AAD 2022, in which he provided guidance on managing patient labs and discussed adjuvant therapies to reduce mucocutaneous dryness and initial acne flares in patients being treated with isotretinoin.

More AAD 2022 Video Coverage

JCAD’s coverage of the 2022 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).